# K171463: ASPIRE Bellus II

- Pathway: 510(k) (Traditional)
- Applicant: Fujifilm Medical Systems U.S.A, Inc.
- Decided: Sep 29, 2017 after 134 days
- Product code: LLZ (System, Image Processing, Radiological)
- Device class: 2
- Regulation: 21 CFR 892.2050
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 12 generations back to K913770 (1991). 112 ancestors in all.
No later device cites it as a predicate yet.
0 of 113 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K160108: Synapse PACS, Fujifilm Medical Systems U.S.A, Inc. (2016) Summary page 4.

## Indications for use
ASPIRE Bellus II is medical imaging software that is intended to provide trained medical imaging professionals, including Physicians and Radiologists, with tools to aid them in reading, interpreting, reporting. This product accepts DICOM compliant medical images acquired from a variety of imaging devices including, MG, CT, PT, MR, CR, DX, and US, etc. This product also provides general 2D/3D viewing and general image processing, measurements, annotations, reporting, printing, storing, and general image administration tools, etc. This product does not accept lossy compressed mammographic images, which should not be used for primary diagnostic interpretation. Display monitors connected to this product for diagnostic interpretation of mammographic images must be approved for use in digital mammography. All images sent to or imported into this product must conform to regulatory requirements. Image quality must conform to applicable quality guidelines.

Source page: https://510kreport.com/device/K171463
Methodology: https://510kreport.com/methodology